Dendritic Cells in Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-cell Lymphoma

Lindsley Yamasaki^*
*Correspondence: Lindsley Yamasaki, Department of Clinical Medicine, The University of Hong Kong, Hong Kong, China, Email:

Introduction

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) has become an essential treatment modality for patients with Diffuse Large B-Cell Lymphoma (DLBCL), one of the most common and aggressive types of non-Hodgkin lymphoma. This procedure involves the collection and transplantation of a patient’s own hematopoietic stem cells after they have undergone high-dose chemotherapy or radiation. While AHSCT has significantly improved survival rates in DLBCL patients, its outcomes can be influenced by several factors, including the composition of the graft and the patient's post-transplant recovery. Among the many components of the hematopoietic graft, Dendritic Cells (DCs), which are key players in the immune system, have emerged as important predictors of post-transplant outcomes. DCs are responsible for initiating immune responses and play a crucial role in both Graft-Versus-Tumor (GVT) effects and the risk of Graft-Versus-Host Disease (GVHD). This article explores the role of dendritic cells in AHSCT for DLBCL, specifically focusing on how the graft content of DCs and the post-transplant recovery of the immune system can predict survival outcomes for patients.

Description

Dendritic cells are professional antigen-presenting cells that bridge the innate and adaptive immune systems. Their primary function is to capture and present antigens to T cells, thus initiating specific immune responses. In the context of hematopoietic stem cell transplantation (HSCT), DCs play a dual role in regulating the immune environment of the recipient.Graft-Versus-Tumor (GVT) Effect: In autologous transplants, the immune system can recognize residual cancer cells as foreign, leading to a graft-versus-tumor effect. Dendritic cells are essential in recognizing and presenting tumor antigens to T cells, thereby triggering an immune response against the tumor cells. This is particularly important in diseases like DLBCL, where the risk of relapse after high-dose chemotherapy remains a concern. Graft-Versus-Host Disease (GVHD): Although more common in allogeneic stem cell transplantation, GVHD can still occur in autologous transplants, especially when there are changes in the patient’s immune system due to the manipulation of the graft. An imbalance in the number or function of dendritic cells in the graft may contribute to increased risk of GVHD, a condition where the immune cells from the graft attack the host tissue [1].

The composition of the hematopoietic stem cell graft has a profound effect on the immune reconstitution and clinical outcomes following AHSCT. Grafts with a higher content of dendritic cells may lead to enhanced immune surveillance, increasing the chances of tumor eradication. Conversely, an imbalance in the DC content could lead to poorer immune recovery, increasing the risk of infection, relapse, and even GVHD. Several studies have shown that the quantity and quality of dendritic cells in the graft are predictive of transplant success. In particular, mature dendritic cells have been associated with better graft-versus-tumor responses and improved survival outcomes, as they are more efficient at antigen presentation and stimulating T cell responses [2]. In contrast, immature dendritic cells might not adequately stimulate an anti-tumor immune response and could contribute to an inadequate immune reconstitution post-transplant. A key finding from recent studies is that the absolute number of dendritic cells in the graft may correlate with improved post-transplant outcomes. Higher dendritic cell numbers in the graft have been linked with a reduced risk of relapse and an enhanced graft-versus-tumor effect. However, the total number of dendritic cells is not the only factor influencing outcomes. The functional status of these cells is equally important. The degree of maturation of dendritic cells at the time of graft infusion can significantly affect the immune system's ability to recognize and eliminate cancer cells [3].

The functionality of dendritic cells after transplantation is also crucial. Post-transplant dendritic cells that are functionally impaired may fail to activate T cells effectively, leading to a weaker graft-versus-tumor response and an increased risk of relapse. Conversely, mature dendritic cells can enhance T cell activation and increase the chances of eliminating residual malignant cells. Research has shown that patients who maintain a robust and functional population of dendritic cells after transplant have better overall survival and progression-free survival rates. The relationship between dendritic cells in the graft and post-transplant recovery offers an important avenue for predicting survival outcomes in patients undergoing AHSCT for DLBCL. Researchers have identified several factors related to graft composition and post-transplant recovery that serve as predictors of survival:: A higher percentage of mature dendritic cells in the graft has been associated with improved survival outcomes. These mature cells are more effective in initiating an anti-tumor immune response and increasing the chances of remission [4].

Conversely, grafts with low dendritic cell content or an abundance of immature DCs may lead to poor immune activation and increased relapse rates. Early and effective recovery of dendritic cells after transplantation is another predictor of survival. Patients who exhibit rapid recovery of dendritic cells tend to have better immune surveillance, fewer infections, and a reduced risk of lymphoma relapse. Conversely, delayed immune recovery can result in a weakened immune system, increasing the risk of post-transplant complications such as infections, GVHD, or tumor relapse. Monitoring the recovery of dendritic cells in the post-transplant period can serve as an important tool for predicting relapse and overall survival. By measuring the circulating levels of dendritic cells or assessing their functional status, clinicians can identify patients at higher risk for relapse or delayed immune recovery. This information could potentially guide targeted therapeutic interventions, such as the use of immunotherapies or cytokines, to boost immune recovery and reduce the risk of relapse [5].

Conclusion

Dendritic cells play a critical role in the success of autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma. The composition of dendritic cells in the graft, as well as the post-transplant recovery of these cells, can significantly influence survival outcomes, graft-versus-tumor effects, and the risk of relapse. Monitoring and enhancing dendritic cell function before and after transplant may help identify high-risk patients and provide opportunities for targeted interventions. Ultimately, further research into dendritic cell.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Mitchell, Emily, Michael Spencer Chapman, Nicholas Williams and Kevin J. Dawson, et al. "Clonal dynamics of haematopoiesis across the human lifespan." Nat 606 (2022): 343-350.

   Google Scholar, Crossref, Indexed at

2. Li, Jian-Feng, Wen-Yan Cheng, Xiang-Jie Lin and Li-Jun Wen, et al. "Aging and comprehensive molecular profiling in acute myeloid leukemia." Proc Natl Acad Sci 121 (2024): e2319366121.

   Google Scholar, Crossref, Indexed at

3. Warren, Julia T. and Daniel C. Link. "Clonal hematopoiesis and risk for hematologic malignancy." Blood, J Am Soc Hematol 136 (2020): 1599-1605.

   Google Scholar, Crossref, Indexed at

4. Avagyan, S., J. E. Henninger, W. P. Mannherz and M. Mistry, J. Yoon, et al. "Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis." Sci 374 (2021): 768-772.

   Google Scholar, Crossref, Indexed at

5. Jaiswal, Siddhartha, Pierre Fontanillas, Jason Flannick and Alisa Manning, et al. "Age-related clonal hematopoiesis associated with adverse outcomes." New Eng J Med 371 (2014): 2488-2498.

   Google Scholar, Crossref, Indexed at